rapid respiratory infection test / Streptococcus A / Streptococcus B / throat



  • Applications:

    for respiratory infections

  • Tested parameter:

    Streptococcus A, Streptococcus B

  • Sample type:



Direct Detection of Streptococcus pyogenes Nucleic Acid in Throat Swab Specimens
ARIES® Group A Strep Assay Overview

Beta-hemolytic Streptococcus pyogenes, known as Group A Strep, causes strep throat, scarlet fever, and other serious health problems. Pharyngitis, the broader category into which Streptococcal pharyngitis falls, is diagnosed in 11 million people annually in the United States.1

Accurate diagnosis of Group A Strep is critical for appropriate treatment and mitigating unnecessary antibiotic use. The ARIES® Group A Strep Assay is a real-time PCR-based qualitative in vitro diagnostic test for the direct detection of Group A β-hemolytic Streptococcus in throat swab specimens from patients with signs and symptoms of pharyngitis. The assay is FDA cleared and CE Marked for IVD use.

The ARIES® Group A Strep Assay delivers higher sensitivity and specificity than existing rapid tests, and a faster turnaround time than culture methods.2